Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Dabrafenib and Trametinib prolong coagulation through the inhibition of tissue factor in BRAFv600e mutated melanoma cells in vitro

Fig. 3

Western blot analysis of total protein extracts of A-375 (a) and SK-MEL-28 (b) cells treated for 48 h with Dabrafenib and Trametinib, alone and in combination, and DMSO as control. The protein species were detected at the expected molecular weights per their datasheets, as follows: β-tubulin ~ 55 kDa; tissue factor (TF) ~ 35 kDa. Protein expression was normalized to their loading control (β-tubulin)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us